VCAM1 and leukemia: Furthermore, the recent work of Jonart et al. showed that reducing leukemia-meningeal adhesion with Me6TREN (Tris[2-(dimethylamino)ethyl]amine) not only reduced leukemia chemoresistance but also the expression levels of several genes including VCAM-1 (82).